The pharma companies AbbVie (headquartered in North Chicago, Illinois in the United States) and Gedeon Richter Plc. (headquartered in Budapest, Hungary) have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. A statement on the website of the Budapest Stock Exchange highlights that this collaboration […]
The new headquarters of Richter Plc. in Kőbánya, the 10th district of the Hungarian capital was inaugurated on Thursday. The 17,400-square-meter building, which provides space for 450 employees, was completed with an investment of HUF 20 billion, financed by the pharmaceutical company from its own resources. Speaking at the opening ceremony, Energy Minister Csaba Lantos […]
The consolidated sales revenue of the pharmaceutical company Gedeon Richter Plc. was HUF 203.4 billion in the first quarter of 2024, 3.0% lower than a year earlier, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Tuesday. Analysts had expected revenues to fall 3.6% to HUF 202 billion. In the […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals SA. In the statement, Richter confirms that it has participated in the monetisation process of Mithra, which was publicly initiated by […]
The pharmaceutical company Sanofi launched its international program "Cancer & Work: Acting Together" in February. It provides support to employees affected by cancer. The company says in a statement that it is providing social, mental and financial support, with up to twelve months of supplementary pay through a health fund, regardless of job title or […]
Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has signed an agreement with HELM AG, a Germany-based stock corporation (“HELM”) to buy 50% stake in Richter-Helm BioTec GmbH & Co. KG (“RHT”); and 30% stake in Richter-Helm BioLogics GmbH & Co. KG. (“RHB”) to become 100% owner of […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it expanded its partnership with Mithra Pharmaceuticals SA with a binding Head of Terms (HoT) agreement for the development and commercialization of the first estetrolbased combined oral contraceptive (15 mg estetrol (E4) / 3 mg drospirenone) and […]
With an investment of HUF 6.2 billion, the most modern pharmaceutical wholesale warehouse in Central and Eastern Europe has been built on 3,000 square meters as the automated high-bay warehouse of Hungaropharma Plc. has been inaugurated The third stage of Hungaropharma's Budapest Logistics Center is not only suitable for the logistics of its own stocks […]
The Swiss multinational healthcare company Roche, one of the largest pharmaceutical companies in the world by revenue and the leading provider of cancer treatments globally, has diversified activities in Hungary: the pharmaceutical, diagnostics and diabetes divisions and the Roche Service&Solution Center employ over 2,000 people altogether. General Manager Raffaella Claudia Bondi, who has been at […]
The Novartis Group has been present in Hungary for more than 25 years. Country President Matt Zeller, the head of its local subsidiary, Novartis Hungary Ltd. elaborates to Diplomacy&Trade on the company’s activities on the Hungarian market with special regard to medical research and development (R&D), an area where the Group is a leading global […]
The Hungarian pharma company Gedeon Richter Plc. and Mithra Pharmaceuticals of Belgium have signed a binding supply agreement for the active pharmaceutical ingredient (API) for the combined oral contraceptive Estelle® and Donesta®, a novel product candidate for the treatment of post-menopausal symptoms. The agreement, announced on the website of the Budapest Stock Exchange, specifies that […]
In the second quarter of this year, Gedeon RichterPlc. achieved a profit after tax of HUF 30.0 billion, 61.1% below the same period last year, in line with analysts' expectations, the pharmaceutical company announced on the website of the Budapest Stock Exchange (BSE) on Friday. Total revenue for the quarter was HUF 203.78 billion, up […]
The Hungarian pharmaceutical company Gedeon Richter Plc. and the Dutch IQ Medical Ventures B.V. have announced on the website of the Budapest Stock Exchange that they signed a Share Purchase Agreement to transfer 100% of the shares of Giskit MD B.V. to Richter from Giskit Holding B.V., the affiliate of IQ Medical. Giskit MD B.V. […]
GSK (formerly GlaxoSmithKline) Plc. is a British multinational biopharma company, one of the top pharma firms in the world. Its plant in Gödöllő, just east of Budapest, has been developed into a strategic actor in GSK’s global vaccine production. The histories of the founders of GSK date back well over a century (in fact, Glaxo's […]
The Eötvös Loránd University (ELTE) of Budapest and the Japanese instrument manufacturer JASCO Corporation have signed an agreement aimed at the development of the pharmaceutical industry, it was announced at the event of the University's Innovation Center's Territorial Innovation Platform (TIP) in the Hungarian capital on Thursday. Balázs Hankó, Minister of State for Innovation and […]
